NUVBNuvation Bio Inc.Running, no new patients
A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene
Non Small Cell Lung Cancer
10Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
- +10
Main results were due Jun 2024, none posted yet
Counts until it's fixed
Worry score10
Score over time
- Stage
- Phase 2
- Patients
- 173 (final count)
- Started
- Jul 7, 2020
- Main results expected
- Jun 7, 2024
- Fully finished
- Jun 2027
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Best overall response (BOR) by IRC
Measured over: 6 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- results_overdue: base 10, now 10, since 2024-06-07, no fading
Raw record changes
- none yet
Trial ID NCT04395677 · record last updated 2026-02-06 · checked 2026-11-09 15:47 UTC